Portal Announces 50 Partners & $7M Seed Round Led by IA Ventures!
Portal News
Check out Portal's latest news! For press or media inquiries, please contact info@portal.bio
Sorting
Businesswire • Press Release
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next... Read more
Businesswire • Press Release
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next... Read more
Boston Business Journal • Media
Founder of SQZ is back with new startup focused on cell therapies
A year after leaving the company he founded, SQZ Biotechnologies, Armon Sharei has a new venture that has a similar approach to getting stuff inside cells. Read more
Boston Business Journal • Media
SQZ founder's new startup goes from zero to $1M in revenue in a year
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Portal Biotechnologies, Inc., a cell engineering platform company, announced its emergence from stealth today. Established in 2023, Portal is implementing a simplified approach to intracellular delivery,... Read more
Fierce Biotech • Media
SQZ founder Armon Sharei opens Portal to simplify intracellular delivery
[...] The Cambridge, Mass.-based biotech hopes to simplify intracellular delivery via new advances in RNA, gene editing and AI-driven discovery tech. Portal’s initial product suite is designed to deliver many different types of cargo to a... Read more
Portal Announces 50 Partners & $7M Seed Round Led by IA Ventures!
